A like-for-like comparison for Knee Osteoarthritis — invasiveness, recovery, evidence level and real cost, side by side, so you can see exactly where each option fits.
Direct answer: For Knee Osteoarthritis, Knee replacement (arthroplasty) is the proven, regulator-backed option (evidence: Strong) but is more invasive (high) with a longer recovery (3–6 months; highly effective). Stem-cell therapy is less invasive (medium) and cheaper (€4,000–15,000 vs €15,000–35,000), but it is investigational — best considered for earlier-stage disease or when you want to delay or avoid surgery, ideally inside a registered trial.
| Option | 证据 | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|
| Stem-cell therapy | Investigational | €4,000–15,000 | Medium | 2–4 weeks; ongoing studies |
| Knee replacement (arthroplasty) | Strong | €15,000–35,000 | High | 3–6 months; highly effective |
First-line management includes weight management and physiotherapy to strengthen supporting muscles and improve biomechanics. Non-steroidal anti-inflammatory drugs (NSAIDs)—ibuprofen, naproxen—reduce pain and inflammation; some individuals use topical creams instead. For moderate OA, intra-articular injections provide targeted relief: corticosteroid injections reduce inflammation for 3–6 weeks, while hyaluronic-acid (viscosupplementation) injections mimic natural joint fluid and may improve symptoms for several months. Walking aids and knee braces reduce load. Advanced cases may require joint replacement (arthroplasty), which is highly effective but invasive. Regular activity, warm water therapy, and weight loss are foundational for all stages.
Regenerative therapies, particularly stem-cell and cartilage-regeneration approaches, are being investigated for knee OA. Bone-marrow-derived or adipose-derived mesenchymal stem cells may promote cartilage repair and reduce inflammation; several clinical trials are ongoing. These treatments remain largely investigational and are not standard care. Candidates may be those with early-to-moderate OA who have not responded adequately to conventional options. See <a href="../treatments/knee-osteoarthritis.html">stem-cell options for knee OA</a> and <a href="../am-i-a-candidate.html">eligibility criteria</a>.
Neither is universally better. Knee replacement (arthroplasty) has the strongest evidence and is definitive, but it is invasive with a 3–6 months; highly effective recovery. Stem-cell therapy is less invasive and cheaper, but unproven — it suits earlier-stage cases or patients avoiding surgery. The right choice depends on your stage, age and goals.
Indicatively €4,000–15,000 for stem-cell therapy versus €15,000–35,000 for Knee replacement (arthroplasty) — but cost should never be the deciding factor for an investigational treatment. Always verify GMP certification and approval status first.
No — for Knee Osteoarthritis it is investigational, not an approved cure. Knee replacement (arthroplasty) is the established standard of care. Check whether a registered ClinicalTrials.gov trial is open before paying for private treatment.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估